Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Ong (Groningen, Netherlands). Target gene identification of TGF-ß-induced miR-455-3p and miR-21-3p in lung fibroblasts. 1025

Member's Comments

No comment yet.

Related content which might interest you: ASCL1 suppress ZFP36L1 expression by regulating miR124-3p expression in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 miR-122-5p and miR-191-5p are increased in plasma small extracellular vesicles in asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 (Array)CGH analysis of chromosomal gains and losses in human malignant pleural mesothelioma cell lines: Involved loci and genes Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Homeobox-genes (HOX) in human lung - altered expression in lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001 The downstream effects of the 17q12-21 asthma region. Is functional splicing of GSDMB the explanation? Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020 Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Abnormal expression of let-7a miRNA in blood of lung cancer patient Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4. Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The expression rate of MAGE A1-6 and SSX4 in lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 457s Year: 2005